238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.98%
Revenue growth 1.25-1.5x PINS's 16.75%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
21.12%
Gross profit growth similar to PINS's 21.27%. Walter Schloss would assume both firms track common industry trends.
23.28%
Positive EBIT growth while PINS is negative. John Neff might see a substantial edge in operational management.
23.28%
Operating income growth under 50% of PINS's 87.79%. Michael Burry would be concerned about deeper cost or sales issues.
23.72%
Net income growth under 50% of PINS's 334.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
-11.54%
Negative EPS growth while PINS is at 334.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.54%
Negative diluted EPS growth while PINS is at 335.66%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
38.33%
Share count expansion well above PINS's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
40.71%
Diluted share count expanding well above PINS's 0.07%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-43.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-60.24%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
152.68%
10Y revenue/share CAGR under 50% of PINS's 310.48%. Michael Burry would suspect a lasting competitive disadvantage.
152.68%
5Y revenue/share CAGR at 50-75% of PINS's 217.57%. Martin Whitman would worry about a lagging mid-term growth trajectory.
152.68%
3Y revenue/share CAGR above 1.5x PINS's 46.66%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.38%
Below 50% of PINS's 166.88%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
21.38%
Below 50% of PINS's 133.35%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
21.38%
Below 50% of PINS's 188.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-45.34%
Our R&D shrinks while PINS invests at 8.43%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-100.00%
We cut SG&A while PINS invests at 22.36%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.